Literature DB >> 27111528

Selone-stabilized aryltellurenyl cations.

Sangeeta Yadav1, Saravanan Raju, Harkesh B Singh, Ray J Butcher.   

Abstract

Controlled bromination of a diarylditelluride, R2Te2 (R = 2,6-dimethylphenyl) (6) in dichloromethane led to the formation of a Te(II)-Te(IV) mixed-valent tellurenyl bromide, RBr2TeTeR (7). A further reaction of 7 with 1,3-dibutylbenzimidazolin-2-selone, C15H22N2Se (L) (9), produced the first selone adduct of the 2,6-dimethylphenyltellurenyl cation with the 2,6-dimethylphenyltellurium dibromide anion, [(2,6-Me2C6H3)Te(L)](+)[(2,6-Me2C6H3)TeBr2](-) (10). The red colored cationic adduct 10 is not stable in acetonitrile and disproportionated to give the selone adduct of 2,6-dimethylphenyltellurenyl bromide, [(2,6-Me2C6H3)Te(L)Br] (11b) and bis(2,6-dimethylphenyl)tellurium dibromide, [(2,6-Me2C6H3)2TeBr2], (13). The metathesis reaction of 11b with AgBF4 produced a stable dark red colored selone adduct of the 2,6-dimethylphenyltellurenyl cation with the BF4(-) anion, [(2,6-Me2C6H3)Te(L)](+)BF4(-) (15). The selone adducts of aryltellurenyl halides, i.e. [(2,6-Me2C6H3)Te(L)X] (X = Cl, Br, I) (11a-11c), have been synthesized by a one-pot reaction of 6 with an equimolar mixture of 9 and 1,3-dibutylbenzimidazolin-2-dihaloselones, C15H22N2SeX2 (14a-14c). Triphenylphosphine (PPh3), when treated with [(2,6-Me2C6H3)Te(L)X] (11a-11c), substitutes selone from the adduct to afford the triphenylphosphine adducts of aryltellurenyl halides, [(2,6-Me2C6H3)Te(PPh3)X] (16a-16c).

Entities:  

Year:  2016        PMID: 27111528     DOI: 10.1039/c6dt01081d

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  1 in total

1.  Synthesis and structure of an aryl-tellurenium(II) cation; [4-tert-butyl-2,6-bis-(1-pentyl-1H-benz-imidazol-2-yl-κN3)phenyl-κC1]tellurium(II) (1,4-dioxane)tri-iodido-mercurate(II).

Authors:  Varsha Rani; Harkesh B Singh; Ray J Butcher
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2018-02-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.